No Data
No Data
No Data
No Data
No Data
Wisdom Pharmaceutical (300149.SZ): Net loss of 254.606 million yuan in the first quarter
On April 26, Ge Longhui Pharmaceutical (300149.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 235 million yuan, a year-on-year decrease of 12.68%; net profit attributable to shareholders of listed companies - 254.606 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - RMB 28.00.94 million; basic earnings per share - 0.0509 yuan.
Gelonghui FinanceApr 26 00:28
CRO concept stocks fluctuated higher, Wisdom Pharmaceuticals rose more than 8%
Gelonghui, March 12 | Wisdom Pharmaceuticals rose more than 8%, followed by Hongbo Pharmaceutical, Pharmaceutical Pharmaceutical, Medici, and Tailong Pharmaceutical.
Gelonghui FinanceMar 12 09:45
Express News | Wisdom Pharmaceutical: Expected net loss of 725 million to 945 million yuan in 2023
BreakingsJan 26 18:37
Express News | Smart Pharmaceuticals: The company is still actively seeking measures to reverse the difficult situation, and is still not considering selling CDMO
BreakingsJan 19 22:28
Wisdom Pharmaceuticals (300149.SZ) elects WOO SWEE LIAN as Chairman
Wisdom Pharmaceutical (300149.SZ) announced that the board of directors of the company reviewed and approved the “Election of Directors for the 5th Board of Directors...
Zhitong FinanceJan 10 18:36
Zhang Jiguo, director and CEO (CEO) of Wisdom Pharmaceutical (300149.SZ), resigns
Wisdom Pharmaceutical (300149.SZ) issued an announcement. The company's board of directors recently received the company's director and CEO (...
Zhitong FinanceDec 29, 2023 18:03
No Data
No Data